CBSA Remains Active on Critical Federal Legislation

Act Today and Tell Your Member of Congress: Oppose Government Price Setting

Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language that imposes government price setting in Medicare. This could chill investment in next-generation treatments and cures for patients in need and result in significant job losses in the biopharmaceutical sector.

As part of a nationwide effort led by our partners at BIO, CBSA is working to mobilize Colorado’s life sciences community. We support health innovation for patients and oppose government price setting. You must act today and email your members of Congress. Voting on this legislation will take place today and go into the weekend. 

Please take a few minutes to take action and write a letter to your member of Congress using our interactive email tool.

Why It Matters

Price setting will harm patients: Efforts by Congress to impose government…
Click here to view original post